Found: 115
Select item for more details and to access through your institution.
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
- Published in:
- Depression & Anxiety (1091-4269), 2010, v. 27, n. 5, p. 417, doi. 10.1002/da.20695
- By:
- Publication type:
- Article
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5236, doi. 10.1002/alz.13872
- By:
- Publication type:
- Article
Scalable Multi‐Sensor At Home Assessment of Sleep and Activity in Adults At High Risk for Dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076469
- By:
- Publication type:
- Article
CAN‐THUMBS UP: Recruitment in the Virtual Era.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075155
- By:
- Publication type:
- Article
Virtual Cognitive Testing‐ Neuropsychology, MyCogHealth and Cogniciti.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075157
- By:
- Publication type:
- Article
Brain Health PRO: An Interactive, Online, Educational Program for Dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075156
- By:
- Publication type:
- Article
Virtual Design of the Brain Health Support Program and CAN‐THUMBS UP.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075153
- By:
- Publication type:
- Article
Asian Cohort for Alzheimer's Disease Pilot Study on Genetic and Non‐Genetic Risk Factors for Alzheimer's Disease among Asian Americans and Canadians.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.076993
- By:
- Publication type:
- Article
A Phase 2a proof‐of‐concept double‐blind, randomized, placebo‐controlled trial of nicotinamide in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077979
- By:
- Publication type:
- Article
Stable Isotope Labelling Kinetics: Models and methods to evaluate APP production rates with Posiphen treatment in the DISCOVER clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077287
- By:
- Publication type:
- Article
CSF tau markers are associated with fine memory discrimination in older adults with amnestic MCI in the EXERT trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080157
- By:
- Publication type:
- Article
Number of completed exercise sessions is associated with slower brain atrophy in MCI over 12 months in the EXERT trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079285
- By:
- Publication type:
- Article
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 1041, doi. 10.1002/alz.12845
- By:
- Publication type:
- Article
Successful Recruitment of Vietnamese Americans into the Asian Cohort for Alzheimer's Disease (ACAD) Pilot Study at UC San Diego.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.067487
- By:
- Publication type:
- Article
Topline Results of EXERT: Can Exercise Slow Cognitive Decline in MCI?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.069700
- By:
- Publication type:
- Article
The Asian Cohort for Alzheimer's Disease (ACAD) Pilot Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.065599
- By:
- Publication type:
- Article
A novel, efficient and seamless Phase 2A‐2B design to test varoglutamstat in early AD: the VIVA‐MIND study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.065197
- By:
- Publication type:
- Article
evoke and evoke+: design of two large‐scale, double‐blind, placebo‐controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.062415
- By:
- Publication type:
- Article
Drug therapy, imaging, and other aspects of clinical management change after Alzheimer's biomarker testing in routine practice: Findings from the IMPACT‐AD BC study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069439
- By:
- Publication type:
- Article
What patients and caregivers do with knowledge of Alzheimer's disease CSF test results: Findings from the IMPACT‐AD BC study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068306
- By:
- Publication type:
- Article
Investigating changes in fluid biomarkers in early Alzheimer's disease: design of plasma biomarker analyses and a cerebrospinal fluid sub‐study in the evoke and evoke+ trials of semaglutide versus placebo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.062382
- By:
- Publication type:
- Article
Committee on High‐quality Alzheimer's Disease Studies (CHADS) consensus report.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1109, doi. 10.1002/alz.12461
- By:
- Publication type:
- Article
Current directions in tau research: Highlights from Tau 2020.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 988, doi. 10.1002/alz.12452
- By:
- Publication type:
- Article
Clinical diagnosis of Alzheimer's disease: Recommendations of the International Working Group (IWG).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051167
- By:
- Publication type:
- Article
Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 11, p. 1808, doi. 10.1002/alz.12401
- By:
- Publication type:
- Article
CAN‐Thumbs UP (Canada): World‐Wide FINGERS network: The first global network of multidomain dementia prevention trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046952
- By:
- Publication type:
- Article
T2 protect AD: Achieving a rapid recruitment timeline in a multi‐site clinical trial for individuals with mild‐to‐moderate Alzheimer's disease: Human: Improving clinical trial methodology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044909
- By:
- Publication type:
- Article
Recruitment for a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial: Prevention (nonpharmacological) / Exercise.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044658
- By:
- Publication type:
- Article
Intensive measurement of cognition to support early detection of cognitive change in individuals at risk of dementia: Advancing clinical trial design and methods in a digital age.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042599
- By:
- Publication type:
- Article
ACI‐24 vaccine in adults with Down syndrome: Human: Putative therapeutic results for Alzheimer's and related dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038678
- By:
- Publication type:
- Article
A phase 1B multiple ascending dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of a medium chain triglyceride supplement in Alzheimer's disease: Brain energy rescue interventions to treat or delay Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037960
- By:
- Publication type:
- Article
P3‐448: PREDICTION OF COGNITIVE STATUS AND 5‐YEAR SURVIVAL FOR ELDERLY WITH HYPERTENSION BY USING THE NEUROCOGNITIVE FRAILTY INDEX (NFI).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1134, doi. 10.1016/j.jalz.2019.06.3482
- By:
- Publication type:
- Article
P2‐168: IMMUNOHISTOCHEMISTRY OF O‐LINKED N‐ACETYLGLUCOSAMINE TRANSFERASE (OGT) AND AUTOPHAGY MARKER LC3B IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P640, doi. 10.1016/j.jalz.2019.06.2575
- By:
- Publication type:
- Article
O1‐09‐04: APPLYING POLYGENIC HAZARD SCORES TO ENRICH CLINICAL TRIAL STUDY POPULATIONS OF THOSE AT RISK OF ALZHEIMER'S DISEASE DEMENTIA (ADD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P218, doi. 10.1016/j.jalz.2019.06.4568
- By:
- Publication type:
- Article
A randomized clinical trial to evaluate home‐based assessment of people over 75 years old.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 5, p. 615, doi. 10.1016/j.jalz.2019.01.007
- By:
- Publication type:
- Article
Participant satisfaction with dementia prevention research: Results from Home‐Based Assessment trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 11, p. 1397, doi. 10.1016/j.jalz.2018.05.016
- By:
- Publication type:
- Article
P3‐032: SCREENING‐TO‐BASELINE COGNITIVE VARIABILITY DOES NOT PREDICT RATE OF DECLINE IN A CLINICAL TRIAL OF MILD‐TO‐MODERATE AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1076, doi. 10.1016/j.jalz.2018.06.1387
- By:
- Publication type:
- Article
P2‐590: ANTICHOLINERGIC MEDICATION USE INTERACTS WITH APOE‐ɛ4 GENOTYPE TO INCREASE RISK FOR INCIDENT MCI OVER A 10‐YEAR PERIOD AMONG COGNITIVELY HEALTHY OLDER ADULTS: AN ALZHEIMER'S DISEASE NEUROIMAGING STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P963, doi. 10.1016/j.jalz.2018.06.1285
- By:
- Publication type:
- Article
O2‐14‐06: DIFFERENCES BETWEEN SPORADIC AND FAMILIAL BEHAVIORAL VARIANT FTD IN ADVANCING RESEARCH AND TREATMENT FOR FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P658, doi. 10.1016/j.jalz.2018.06.2723
- By:
- Publication type:
- Article
O2‐14‐02: THE CLINICAL SPECTRUM OF FRONTOTEMPORAL LOBAR DEGENERATION IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 912 PARTICIPANTS FROM THE ADVANCING RESEARCH AND TREATMENT IN FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P656, doi. 10.1016/j.jalz.2018.06.2719
- By:
- Publication type:
- Article
P1‐433: GRAY MATTER DEFICITS IN SYMPTOMATIC AND PRESYMPTOMATIC MAPT MUTATION CARRIERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P475, doi. 10.1016/j.jalz.2018.06.442
- By:
- Publication type:
- Article
The "rights" of precision drug development for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13195-019-0529-5
- By:
- Publication type:
- Article
Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY).
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0427-2
- By:
- Publication type:
- Article
Early Neuropsychological Characteristics of Progranulin Mutation Carriers.
- Published in:
- Journal of the International Neuropsychological Society, 2014, v. 20, n. 7, p. 694, doi. 10.1017/S1355617714000551
- By:
- Publication type:
- Article
An exploration of cognitive subgroups in Alzheimer's disease.
- Published in:
- Journal of the International Neuropsychological Society, 2010, v. 16, n. 2, p. 233, doi. 10.1017/S1355617709991160
- By:
- Publication type:
- Article
Potential for misclassification of mild cognitive impairment: A study of memory scores on the Wechsler Memory Scale-III in healthy older adults.
- Published in:
- Journal of the International Neuropsychological Society, 2008, v. 14, n. 3, p. 463, doi. 10.1017/S1355617708080521
- By:
- Publication type:
- Article
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302998
- By:
- Publication type:
- Article
A PHASE 2 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF EDONERPIC (T-817) IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1572, doi. 10.1016/j.jalz.2017.07.736
- By:
- Publication type:
- Article
EXERT: A PHASE 3 MULTI-SITE RANDOMIZED CONTROLLED TRIAL OF AEROBIC EXERCISE IN MCI — STUDY DESIGN AND METHODS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P613, doi. 10.1016/j.jalz.2017.06.672
- By:
- Publication type:
- Article
BIOMARKERS ARE USEFUL IN TERTIARY CARE CLINICAL DECISION-MAKING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P370, doi. 10.1016/j.jalz.2016.06.692
- By:
- Publication type:
- Article